scholarly journals Diagnostic Accuracy of Rectal Tumor Staging MRI in Evaluating Extramural Vascular Invasion

2020 ◽  
Vol 7 (1) ◽  
pp. 247-250
Author(s):  
Khalid Khan ◽  
◽  
Noor Shamlooh ◽  
Shaima Shousha ◽  
Nawal Al Hamar ◽  
...  
1997 ◽  
Vol 37 (6) ◽  
pp. 1075
Author(s):  
Hyo Jun Kang ◽  
Taik Kun Kim ◽  
Sang Hoon Cha ◽  
Cheol Min Park ◽  
In Ho Cha ◽  
...  

2014 ◽  
Vol 140 (12) ◽  
pp. 2077-2086 ◽  
Author(s):  
RenBao Yang ◽  
ManPeng Lu ◽  
XiaoXing Qian ◽  
Jiong Chen ◽  
Liang Li ◽  
...  

Esophagus ◽  
2007 ◽  
Vol 4 (4) ◽  
pp. 145-153 ◽  
Author(s):  
Miwako Arima ◽  
Hideaki Arima ◽  
Masahiro Tada ◽  
Youichi Tanaka

2020 ◽  
Author(s):  
Ferdinand Bauer

The preoperative imaging diagnosis of rectal cancer lies at the heart of oncological staging and has a crucial influence on patient management and therapy planning. Rectal cancer is common, and accurate preoperative staging of tumors using high-resolution magnetic resonance imaging (MRI) is a crucial part of modern multidisciplinary team management (MDT). Indeed, rectal MRI has the ability to accurately evaluate a number of important findings that maBay impact patient management, including distance of the tumor to the mesorectal fascia, presence of lymph nodes, presence of extramural vascular invasion (EMVI), and involvement of the anterior peritoneal reflection/peritoneum and the sphincter complex. Many of these findings are difficult to assess in non-expert hands. In this chapter, we present currently used staging modalities with focus on MRI, including optimization of imaging techniques, tumor staging, interpretation help as well as essentials for reporting.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jia Guo ◽  
Zhaoqi Wang ◽  
Jianjun Qin ◽  
Hongkai Zhang ◽  
Wentao Liu ◽  
...  

Abstract Background Patients with esophageal cancer (EC) undergo endoscopic ultrasound and CT based cancer staging. Recent technical developments allow improved MRI quality with diminished motion artifact that may allow MRI to compare favorable to CT for noninvasive staging. Hence the purpose of the study was to assess image quality and diagnostic accuracy of 3 T MRI versus CT and EUS for preoperative T-staging of potentially resectable esophageal cancer. Methods Between October-2014 and December-2017, esophageal cancer patients with T-staging by EUS were enrolled in this prospective study. Post-operative histopathologic T-staging was the reference standard. All participants underwent MRI [T2- multi-shot turbo spin echo sequence (msTSE), diffusion-weighted imaging (DWI), and 3D gradient-echo based sequence (3D-GRE)] and CT [non-contrast and multiphase contrast-enhanced CT scanning] 5.6 + 3.6 days after endoscopy. Surgery was performed within 3.6 + 3.5 days after imaging. Two blinded endoscopists (reader 1 and 2) and radiologists (reader 3 and 4) independently evaluated EUS and CT/MRI, respectively. Considering the clinical relevance, patients were dichotomized into early (T1 and T2) vs late (T3 and T4) stage cancer before assessment. For statistical purpose, the binary decision was defined as the ability of the imaging technique to diagnose early stage/not early stage esophageal cancer. Diagnostic performance of EUS, MRI and CT was compared using McNemar’s test with Bonferroni correction; kappa values were assessed for reader performance. Results 74 study participants (60 ± 8 yrs.; 56 men) with esophageal cancer were evaluated, of whom 85%(63/74) had squamous cell carcinoma, 61%(45/74) were at early stage and 39%(29/74) were at late stage cancer, as determined by histopathology. Intra- and Inter-reader agreement for pre-operative vs post-operative T-staging was excellent for all imaging modalities. Compared to CT, MRI showed significantly higher accuracy for both the readers (reader3: 96% vs 82%, p = 0.0038, reader4: 95% vs 80%, p = 0.0076, for MRI vs CT, respectively). Further, MRI outperformed EUS with higher specificity (reader 1 vs 3: 59% vs 93%, p = 0.0015, reader 2 vs 4: 66% vs 93%, p = 0.0081, for EUS vs MRI respectively), and accuracy (reader 1 vs 3: 81% vs 96%, p = 0.0022, reader 2 vs 4: 85% vs 95%, p = 0.057, for EUS vs MRI, respectively). Conclusion For resectable esophageal cancer, MRI had better diagnostic performance for tumor staging compared to CT and EUS. Trial registration ChiCTR, ChiCTR-DOD, Registered 2nd October 2014, http://www.chictr.org.cn/showproj.aspx?proj=9620


Sign in / Sign up

Export Citation Format

Share Document